Evidence map›Paper›PMID 32282914›Full record

ReviewCardiovascular research2021

Endothelial function in cardiovascular medicine: a consensus paper of the European Society of Cardiology Working Groups on Atherosclerosis and Vascular Biology, Aorta and Peripheral Vascular Diseases, Coronary Pathophysiology and Microcirculation, and Thrombosis.

Yvonne Alexander, Elena Osto, Arno Schmidt-Trucksäss, Michael Shechter, Danijela Trifunovic, Dirk J Duncker, Victor Aboyans, Magnus Bäck, Lina Badimon, Francesco Cosentino and 15 more

Open access · bronzeAbstract readReviewConsensus Statement
In one paragraph

Review in Cardiovascular research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 224 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
224citing papers in PubMed, 2 pooled it
24.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

224 citing papers in PubMed, 2 syntheses or guidelines pooled it, 361 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Early atherogenesis: In search of etiology.International journal of cardiology. Cardiovascular risk and prevention · 2026
    Review
  8. Observational
  9. Postmenopausal Osteoporosis, Endothelial Dysfunction, and Cardiovascular Risk.Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases · 2026
    Article
  10. Current issues in molecular biology · 2026
    Review
  11. Observational
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

164 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 20 institutions in 13 countries.

Yvonne AlexanderCentre for Bioscience, Faculty of Science & Engineering, Manchester Metropolitan University, Manchester, UK.
Elena OstoInstitute of Clinical Chemistry, University and University Hospital Zurich, University Heart Center, Zurich, Switzerland.
Arno Schmidt-TrucksässDivision of Sports and Exercise Medicine, Department of Sport, Exercise and Health, Medical Faculty, University of Basel, Basel, Switzerland.
Michael ShechterLeviev Heart Center, Chaim Sheba Medical Center, Tel Hashomer, Israel.
Danijela TrifunovicCardiology Department, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Dirk J DunckerDivision of Experimental Cardiology, Department of Cardiology, Thoraxcenter, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Victor AboyansDepartment of Cardiology, Dupuytren University Hospital, Inserm U-1094, Limoges University, Limoges, France.
Magnus BäckDepartment of Cardiology, Center for Molecular Medicine, Karolinska University Hospital, Solna, Stockholm, Sweden.
Lina BadimonCardiovascular Program-ICCC, IR-Hospital de la Santa Creu i Sant Pau, CiberCV, Autonomous University of Barcelona, Barcelona, Spain.
Francesco CosentinoUnit of Cardiology, Karolinska Institute and Karolinska University Hospital, Solna, Stockholm, Sweden.
Marco De CarloCatheterization Laboratory, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
Maria Dorobantu'CarolDavila' University of Medicine and Pharmacy, Bucharest, Romania.
David G HarrisonVanderbilt University School of Medicine, Nashville, TN, USA.
Tomasz J GuzikInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
Imo HoeferLaboratory of Clinical Chemistry and Hematology, University Medical Centre Utrecht, The Netherlands.
Paul D MorrisDepartment of Infection, Immunity and Cardiovascular Disease, Bateson Centre & INSIGNEO Institute, University of Sheffield, Sheffield S10 2RX, UK.
Giuseppe D NorataDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan, Italy.
Rosa SuadesUnit of Cardiology, Karolinska Institute and Karolinska University Hospital, Solna, Stockholm, Sweden.
Stefano TaddeiDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Gemma VilahurCardiovascular Program-ICCC, IR-Hospital de la Santa Creu i Sant Pau, CiberCV, Autonomous University of Barcelona, Barcelona, Spain.
Johannes WaltenbergerDepartment of Cardiovascular Medicine, Medical Faculty, University of Münster, Münster, Germany.
Christian WeberInstitute for Cardiovascular Prevention (IPEK), Ludwig-Maximillian-Universität (LMU) München, Munich, Germany.
Fiona WilkinsonCentre for Bioscience, Faculty of Science & Engineering, Manchester Metropolitan University, Manchester, UK.
Marie-Luce Bochaton-PiallatDepartment of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Paul C EvansDepartment of Infection, Immunity and Cardiovascular Disease, Bateson Centre & INSIGNEO Institute, University of Sheffield, Sheffield S10 2RX, UK.
Karolinska University Hospital · SEInsigneo · GBManchester Metropolitan University · GBUniversitat Autònoma de Barcelona · ESAzienda Ospedaliera Universitaria Pisana · ITCarol Davila University of Medicine and Pharmacy · ROErasmus MC · NLInserm · FRJagiellonian University · PLMaastricht University · NLTel Aviv University · ILUniversity Hospital of Zurich · CHUniversity Medical Center Utrecht · NLUniversity of Basel · CHUniversity of Belgrade · RSUniversity of Geneva · CHUniversity of Milan · ITUniversity of Münster · DEUniversity of Pisa · ITVanderbilt University · US

Funding

The Role of Inflammation in Cardiovascular DiseaseP01HL129941 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNSTEIN, KENNETH E · 2016 to 2020
$12.4M
Mechanisms of Immune Activation in HypertensionR35HL140016 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HARRISON, DAVID G · 2018 to 2024
$5.3M
British Heart Foundation RG/19/10/34506European Research Council 692511NHLBI NIH HHS P01 HL129941NHLBI NIH HHS R35 HL140016Wellcome TrustWellcome Trust 214567/Z/18/Z
6 · The paper itself

Abstract

Endothelial cells (ECs) are sentinels of cardiovascular health. Their function is reduced by the presence of cardiovascular risk factors, and is regained once pathological stimuli are removed. In this European Society for Cardiology Position Paper, we describe endothelial dysfunction as a spectrum of phenotypic states and advocate further studies to determine the role of EC subtypes in cardiovascular disease. We conclude that there is no single ideal method for measurement of endothelial function. Techniques to measure coronary epicardial and micro-vascular function are well established but they are invasive, time-consuming, and expensive. Flow-mediated dilatation (FMD) of the brachial arteries provides a non-invasive alternative but is technically challenging and requires extensive training and standardization. We, therefore, propose that a consensus methodology for FMD is universally adopted to minimize technical variation between studies, and that reference FMD values are established for different populations of healthy individuals and patient groups. Newer techniques to measure endothelial function that are relatively easy to perform, such as finger plethysmography and the retinal flicker test, have the potential for increased clinical use provided a consensus is achieved on the measurement protocol used. We recommend further clinical studies to establish reference values for these techniques and to assess their ability to improve cardiovascular risk stratification. We advocate future studies to determine whether integration of endothelial function measurements with patient-specific epigenetic data and other biomarkers can enhance the stratification of patients for differential diagnosis, disease progression, and responses to therapy.

Indexed as

VasodilationAnimalsCardiovascular DiseasesDiagnostic Techniques, CardiovascularEndothelial CellsEndothelium, VascularHeart Disease Risk FactorsHumansObserver VariationPhenotypePredictive Value of TestsPrognosisReproducibility of ResultsRisk AssessmentCardiovascularEndothelial function

Identifiers

PMID32282914
PMCPMC7797212
OpenAlexW3015197361

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.